PharmGen Science, Inc. (KRX:004720)
South Korea · Delayed Price · Currency is KRW 3,480.00
+155.00 (4.66%)
Jul 21, 2026, 3:30 PM KST
PharmGen Science Market Cap
PharmGen Science has a market cap or net worth of 78.69 billion as of July 21, 2026. Its market cap has decreased by -4.14% in one year.
Market Cap
78.69B
Enterprise Value
84.04B
Revenue
171.66B
Ranking
n/a
PE Ratio
668.29
Stock Price
3,480.00
ChartMarket Cap Chart
Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 78.69B, an increase of 622.47%. That is a compound annual growth rate of 6.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 78.69B | -13.57% |
| Dec 30, 2025 | 91.05B | 22.74% |
| Dec 30, 2024 | 74.18B | -33.39% |
| Dec 28, 2023 | 111.36B | 5.58% |
| Dec 29, 2022 | 105.47B | -33.88% |
| Dec 30, 2021 | 159.51B | -3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.62T |
| Celltrion | 40.32T |
| ALTEOGEN | 14.81T |
| Samsung Epis Holdings | 9.85T |
| DRTECH | 81.56B |
| Access Bio | 81.08B |
| iNtRON Biotechnology | 79.35B |
| Enzychem Lifesciences | 76.86B |